Martingale Asset Management L P Amgen Inc Transaction History

Martingale Asset Management L P

$4.27 Billion
Q3 2024

A detailed history of Martingale Asset Management L P transactions in Amgen Inc stock. As of the latest transaction made, Martingale Asset Management L P holds 77,351 shares of AMGN stock, worth $21.7 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares

77,351

Previous 92,728 16.58%

Holding current value

$21.7 Million

Previous $29 Million 13.98%

% of portfolio

0.58%

Previous 0.64%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$309.38 - $337.38 $4.76 Million - $5.19 Million	-15,377 Reduced 16.58%	77,351 $24.9 Million
Q2 2024 Aug 12, 2024	SELL	$262.75 - $319.31 $1.59 Million - $1.94 Million	-6,062 Reduced 6.14%	92,728 $29 Million
Q1 2024 May 14, 2024	SELL	$268.87 - $324.56 $3.72 Million - $4.49 Million	-13,820 Reduced 12.27%	98,790 $28.1 Million
Q4 2023 Feb 12, 2024	SELL	$255.7 - $288.46 $2.36 Million - $2.66 Million	-9,229 Reduced 7.57%	112,610 $32.4 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $1.51 Million - $1.88 Million	-6,913 Reduced 5.37%	121,839 $32.7 Million
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $1.38 Million - $1.63 Million	-6,430 Reduced 4.76%	128,752 $28.6 Million
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $191,469 - $233,369	848 Added 0.63%	135,182 $32.7 Million
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $3.8 Million - $4.83 Million	-16,582 Reduced 10.99%	134,334 $35.3 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $670,237 - $755,905	-2,986 Reduced 1.94%	150,916 $34 Million
Q2 2022 Aug 11, 2022	SELL	$230.71 - $256.74 $3.41 Million - $3.79 Million	-14,770 Reduced 8.76%	153,902 $37.4 Million
Q1 2022 May 12, 2022	SELL	$219.27 - $242.57 $2.93 Million - $3.24 Million	-13,352 Reduced 7.34%	168,672 $40.8 Million
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $1.1 Million - $1.25 Million	-5,513 Reduced 2.94%	182,024 $40.9 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $6.67 Million - $7.81 Million	-31,405 Reduced 14.34%	187,537 $39.9 Million
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $2.19 Million - $2.43 Million	-9,389 Reduced 4.11%	218,942 $53.4 Million
Q1 2021 May 13, 2021	BUY	$221.91 - $258.6 $607,811 - $708,305	2,739 Added 1.21%	228,331 $56.8 Million
Q4 2020 Feb 10, 2021	BUY	$216.38 - $257.67 $4.65 Million - $5.54 Million	21,501 Added 10.54%	225,592 $51.9 Million
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $2.01 Million - $2.24 Million	8,579 Added 4.39%	204,091 $51.9 Million
Q2 2020 Aug 10, 2020	BUY	$197.81 - $242.74 $20.5 Million - $25.2 Million	103,611 Added 112.74%	195,512 $46.1 Million
Q1 2020 May 11, 2020	BUY	$182.24 - $241.7 $7.86 Million - $10.4 Million	43,116 Added 88.38%	91,901 $18.6 Million
Q4 2019 Feb 10, 2020	BUY	$189.21 - $243.2 $4.53 Million - $5.82 Million	23,950 Added 96.44%	48,785 $11.8 Million
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $2.57 Million - $3.07 Million	-14,738 Reduced 37.24%	24,835 $4.81 Million
Q2 2019 Aug 13, 2019	SELL	$166.7 - $195.41 $567,113 - $664,784	-3,402 Reduced 7.92%	39,573 $0
Q1 2019 May 08, 2019	BUY	$180.87 - $203.88 $2.02 Million - $2.28 Million	11,195 Added 35.23%	42,975 $0
Q4 2018 Feb 11, 2019	BUY	$178.4 - $208.25 $17,840 - $20,825	100 Added 0.32%	31,780 $6.19 Million
Q3 2018 Nov 09, 2018	SELL	$185.29 - $208.89 $314,622 - $354,695	-1,698 Reduced 5.09%	31,680 $0
Q2 2018 Aug 09, 2018	BUY	$166.05 - $186.51 $2.16 Million - $2.42 Million	12,998 Added 63.78%	33,378 $0
Q1 2018 May 11, 2018	SELL	$169.43 - $198.0 $67,433 - $78,804	-398 Reduced 1.92%	20,380 $0
Q4 2017 Feb 12, 2018	SELL	$168.79 - $188.59 $16,710 - $18,670	-99 Reduced 0.47%	20,778 $0
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $3.49 Million - $3.99 Million	20,877	20,877 $3.89 Million

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Martingale Asset Management L P with notifications on news.

Account

Martingale Asset Management L P Amgen Inc Transaction History